Suppr超能文献

尿液pH值对西诺沙星在人体内药代动力学及体外抗菌活性的影响。

Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.

作者信息

Barbhaiya R H, Gerber A U, Craig W A, Welling P G

出版信息

Antimicrob Agents Chemother. 1982 Mar;21(3):472-80. doi: 10.1128/AAC.21.3.472.

Abstract

The impact of acidification and alkalinization of the urine on the pharmacokinetics of cinoxacin was examined after single 500-mg oral doses were administered to nine healthy male volunteers. Acidic and alkaline conditions were achieved by repeated oral doses of ammonium chloride or sodium bicarbonate, respectively. Plasma cinoxacin levels in all subjects were adequately described in terms of one-compartment-model kinetics with first-order absorption and elimination. Acidification and alkalinization treatment had no effect on cinoxacin absorption or distribution. The mean elimination half-life of cinoxacin in plasma was 1.1, 2.0, and 0.6 h in control subjects and with acidification and alkalinization of urine, respectively. Recovery of intact cinoxacin in samples of urine collected 0 to 36 h after cinoxacin administration represented 65% of the dose in control subjects and urine acidification and 80% of the dose with alkalinization of urine. The mean renal clearance of cinoxacin was 76, 118, and 278 ml/min with acidification, control, and alkalinization, respectively, and renal clearance was highly correlated with urinary pH. Urine concentrations of cinoxacin were significantly higher with alkalinization compared with control values during the first 4 h after drug administration. Urine cinoxacin concentrations were reduced somewhat by acidification, but these tended not to be significantly different from control values. Changes in cinoxacin elimination owing to urine pH are less pronounced in humans than in dogs. The antibacterial activity of cinoxacin against some common urinary tract pathogens was pH dependent. A four- to eightfold reduction in cinoxacin activity was generally observed at pH 8 compared with lower pH values. However, in view of the high levels of cinoxacin which are obtained in both acidic and basic urine, the impact of urine pH on cinoxacin antibacterial efficacy would be of minor clinical importance.

摘要

在9名健康男性志愿者单次口服500毫克剂量后,研究了尿液酸化和碱化对西诺沙星药代动力学的影响。分别通过重复口服氯化铵或碳酸氢钠来实现酸性和碱性条件。所有受试者的血浆西诺沙星水平均可用具有一级吸收和消除的单室模型动力学进行充分描述。酸化和碱化处理对西诺沙星的吸收或分布没有影响。在对照受试者以及尿液酸化和碱化的情况下,血浆中西诺沙星的平均消除半衰期分别为1.1、2.0和0.6小时。在西诺沙星给药后0至36小时收集的尿液样本中,完整西诺沙星的回收率在对照受试者和尿液酸化时占给药剂量的65%,尿液碱化时占给药剂量的80%。西诺沙星的平均肾清除率在酸化、对照和碱化时分别为76、118和278毫升/分钟,肾清除率与尿液pH高度相关。与给药后前4小时的对照值相比,碱化时尿液中西诺沙星的浓度显著更高。酸化使尿液中西诺沙星的浓度有所降低,但这些浓度往往与对照值无显著差异。与犬类相比,尿液pH对西诺沙星消除的影响在人类中不太明显。西诺沙星对一些常见尿路病原体的抗菌活性取决于pH。与较低pH值相比,在pH 8时通常观察到西诺沙星活性降低4至8倍。然而,鉴于在酸性和碱性尿液中均可获得高浓度的西诺沙星,尿液pH对西诺沙星抗菌疗效的影响在临床上的重要性较小。

相似文献

5
Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.
Pharmacotherapy. 1982 Sep-Oct;2(5):266-72. doi: 10.1002/j.1875-9114.1982.tb03195.x.
6
Time-dependent elimination of cinoxacin in rats.大鼠中西诺沙星的时间依赖性消除。
J Pharm Sci. 1984 Dec;73(12):1697-700. doi: 10.1002/jps.2600731208.
7
Pharmacology of cinoxacin in humans.西诺沙星在人体中的药理学。
Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验